PLAY PODCASTS
Vocalis Health CEO Tal Wenderow on Vocal Biomarkers, Healthcare, and Coronavirus - Voicebot Podcast Ep 145
Season 1 · Episode 145

Vocalis Health CEO Tal Wenderow on Vocal Biomarkers, Healthcare, and Coronavirus - Voicebot Podcast Ep 145

The Voicebot Podcast

April 12, 20201h 3m

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Tal Wanderow is CEO of Vocalis. He and host Bret Kinsella discuss the latest progress behind employing vocal biomarkers to evaluate health conditions and risks. We go into detail about the current work behind tools for diagnosing and monitoring COVID-19 patients. We even explore the ethics of what data patients should have a right to access.

Vocalis Health is focused on using vocal biomarkers to identify the likelihood of hospitalization for a variety of conditions and have another product focused on respiratory disease detection and monitoring. Given that background, it's not surprising that the company has taken a prominent role in the healthcare industry response to the coronavirus pandemic.